[PDF] bmj.com

Cardiovascular manifestations and treatment considerations in COVID-19

Y Kang, T Chen, D Mui, V Ferrari, D Jagasia… - Heart, 2020 - heart.bmj.com
Since its recognition in December 2019, covid-19 has rapidly spread globally causing a
pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular …
被引用次数：469 相关文章 所有 13 个版本
[HTML] nih.gov

Cardiovascular implications of the COVID-19 pandemic: a global perspective

M Boukhris, A Hillani, F Moroni, MS Annabi… - Canadian Journal of …, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …
被引用次数：235 相关文章 所有 9 个版本
[HTML] nih.gov

SARS-CoV-2 infection and cardiovascular disease: COVID-19 heart

BP Dhakal, NK Sweitzer, JH Indik, D Acharya… - Heart, lung and …, 2020 - Elsevier
Coronavirus disease (COVID-19) is a serious illness caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). The symptoms of the disease range from …
被引用次数：212 相关文章 所有 9 个版本
[HTML] nih.gov

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

TJ Guzik, SA Mohiddin, A Dimarco, V Patel… - Cardiovascular …, 2020 - academic.oup.com
The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …
被引用次数：1644 相关文章 所有 26 个版本
[PDF] springer.com

COVID-19 pandemic: cardiovascular complications and future implications

D Bandyopadhyay, T Akhtar, A Hajra, M Gupta… - American Journal of …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is now a global pandemic with the highest number …
被引用次数：148 相关文章 所有 12 个版本
[HTML] nih.gov

Cardiac involvement of COVID-19: a comprehensive review

WT Chang, HS Toh, CT Liao, WL Yu - The American journal of the medical …, 2021 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2 caused …
被引用次数：171 相关文章 所有 12 个版本
[PDF] springer.com

Cardiovascular complications of COVID-19: pharmacotherapy perspective

AH Talasaz, H Kakavand, B Van Tassell… - … drugs and therapy, 2021 - Springer
Abstract Coronavirus disease of 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly the world over. The …
被引用次数：57 相关文章 所有 9 个版本
[PDF] lww.com

Cardiovascular manifestation and treatment in COVID-19

YB Su, MJ Kuo, TY Lin, CS Chien… - Journal of the …, 2020 - journals.lww.com
The novel coronavirus disease 2019 (COVID-19), with first presentation of atypical
pneumonia, has spread rapidly from Wuhan, China, on December 12, 2019 to over 200 …
被引用次数：45 相关文章 所有 7 个版本
[HTML] nih.gov

A current review of COVID-19 for the cardiovascular specialist

JP Lang, X Wang, FA Moura, HK Siddiqi… - American heart …, 2020 - Elsevier
Abstract Although coronavirus disease 2019 (COVID-19) predominantly disrupts the
respiratory system, there is accumulating experience that the disease, particularly in its more …
被引用次数：135 相关文章 所有 7 个版本
[HTML] nih.gov

Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic

S Ganatra, SS Dani, S Shah, A Asnani… - Trends in cardiovascular …, 2020 - Elsevier
Patients with pre-existing cardiovascular disease and risk factors are more likely to
experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID …
被引用次数：74 相关文章 所有 10 个版本